Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-10-24-Speech-2-036"
| Predicate | Value (sorted: none) |
|---|---|
| lpv:spokenAs | |
| lpv:spokenAs | |
| lpv:spokenAs | |
| lpv:spokenAs | |
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@et5
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@sl19
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@mt15
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@cs1
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@sk18
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@lt14
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@pl16
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@hu11
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Fru formand! Jeg vil også gerne takke fru Jöns for dette glimrende initiativ. Hun har gjort et meget stort stykke arbejde med det.
Risikoen for at udvikle brystkræft i løbet af livet for europæiske kvinder er, som vi har hørt, en ud af 10, og det er den største dræber af kvinder mellem 35 og 59 og den næststørste i alt. Hr. Bowis havde helt ret. Vi må ikke glemme, at selv om det hovedsagelig rammer kvinder, dør 1.000 mænd af brystkræft hvert år.
Der gøres stadig ikke nok af medlemsstaterne. Med avanceret screeningsteknik er det muligt at identificere brystkræft på et tidligt stadium. Kommissionen offentliggjorde nye retningslinjer for brystkræftscreening og diagnose af brystkræft i april. Det var deres vurdering, at man kunne undgå 32.000 dødsfald af brystkræft i hele Europa. Men mange medlemsstater har ikke tekniske screeningsfaciliteter eller kvalificerede sygeplejersker til det. Jeg opfordrer alle medlemsstater til at skrive under på de europæiske retningslinjer, men, hvad der er mere vigtigt, at gennemføre disse retningslinjer.
Vi må gøre endnu mere, når det gælder uddannelse. Livsstil kan tilsyneladende lige så vel som genetik påvirke sandsynligheden for, at man får brystkræft. Vi må også sikre os, at de, der får diagnosen brystkræft, ikke bliver udsat for diskrimination på arbejdsmarkedet, som vi allerede har hørt. De bør have lov til at fortsætte med at arbejde under deres behandling, hvis det er det, de ønsker at gøre. Men hvis ikke, bør de have mulighed for at genoptage deres karriere bagefter. Det burde være dækket af beskæftigelsesdirektivet fra 2000 om antidiskrimination på arbejdspladsen - det har vi gjort i Det Forenede Kongerige. Men mange medlemsstater klassificerer ikke brystkræft som et handicap, hvilket er grunden til, at vi har brug for en definition af et handicap. Når der er så mange mennesker, der udvikler brystkræft, må vi sørge for at få dette på det rene.
Vi må også have en udveksling af bedste praksis, særlig eftersom dødeligheden varierer med 50 % fra den ene medlemsstat til den anden. Det er op til os alle at holde denne sag højt på den politiske dagsorden."@da2
|
| lpv:translated text |
".
Fru talman! Jag skulle också vilja tacka Karin Jöns för detta fantastiska initiativ. Hon har lagt ned en oerhörd mängd arbete på det.
Risken för europeiska kvinnor att utveckla bröstcancer under sin livstid är, som vi har hört, en på tio, och det är den största dödsorsaken för kvinnor i åldern 35–59 år, och den andra största totalt sett. John Bowis hade fullkomligt rätt: vi får inte glömma bort att även om sjukdomen huvudsakligen drabbar kvinnor, så dör ettusen män av bröstcancer årligen.
Ändå gör medlemsstaterna inte tillräckligt. Med avancerad undersökningsteknik är det möjligt att identifiera bröstcancer på ett tidigt stadium. Europeiska kommissionen offentliggjorde en ny rad riktlinjer om bröstcancerscreening och bröstcancerdiagnostisering i april. Man uppskattade att 32 000 dödsfall orsakade av bröstcancer inom EU skulle kunna förebyggas. Men många medlemsstater har inte tekniska undersökningsinstrument eller utbildade sköterskor på plats. Jag uppmanar alla medlemsstater att underteckna de europeiska riktlinjerna, men också, och ändå viktigare, att tillämpa dessa riktlinjer.
Vi måste göra ännu mer på utbildningsområdet. Livsstil, liksom genetik, kan uppenbarligen påverka sannolikheten för att drabbas av bröstcancer. Vi måste också se till att de som får diagnosen bröstcancer inte diskrimineras på arbetsplatsen, som vi redan har hört. De borde tillåtas fortsätta arbeta under behandlingen om det är deras önskan, och i annat fall få möjligheter att återuppta sin karriär efteråt. Detta borde innefattas i sysselsättningsdirektivet från 2000 om antidiskriminering på arbetsplatsen – vi har gjort det i Storbritannien. Men många medlemsstater klassificerar inte bröstcancer som ett funktionshinder, och därför behöver vi en definition av funktionshinder. Eftersom så många människor utvecklar bröstcancer måste vi få detta rätt.
Vi måste också ha ett utbyte av bästa metoder, särskilt eftersom dödstalen varierar med 50 procent mellan medlemsstaterna. Det är allas vårt ansvar att sätta upp detta högt på den politiska agendan."@sv21
|
| lpv:translated text |
"Arvoisa puhemies, minäkin haluan kiittää jäsen Jönsiä mainiosta aloitteesta. Hän on tehnyt sen parissa valtavan työmäärän.
Kuten kuulimme, joka kymmenennellä eurooppalaisella naisella on elinikäinen riski sairastua rintasyöpään, ja se on 35–59-vuotiaiden naisten yleisin kuolinsyy ja kaiken kaikkiaan toiseksi yleisin kuolinsyy. Jäsen Bowis oli täysin oikeassa: on muistettava, että vaikka rintasyövästä kärsivät pääasiassa naiset, siihen kuolee vuosittain tuhat miestä.
Jäsenvaltioiden toimet eivät vieläkään ole riittävät. Kehittyneillä seulontamenetelmillä rintasyöpä voidaan havaita varhaisessa vaiheessa. Euroopan komissio julkaisi huhtikuussa rintasyöpäseulontaa ja -diagnoosia koskevat uudet ohjeet. Niiden mukaan Euroopassa voitaisiin estää arviolta 32 000 rintasyöpäkuolemaa. Monilla jäsenvaltioilla ei kuitenkaan ole teknistä seulontalaitteistoa tai koulutettuja sairaanhoitajia. Kehotan kaikkia jäsenvaltioita sitoutumaan eurooppalaisiin ohjeisiin, mutta ennen kaikkea panemaan ne täytäntöön.
Koulutukseen on panostettava vieläkin enemmän. Elintavat ja perintötekijät saattavat ilmeisesti vaikuttaa rintasyöpään sairastumisen todennäköisyyteen. Kuten kuulimme, on huolehdittava myös siitä, ettei rintasyöpään sairastuneita syrjitä työpaikalla. Heidän on voitava jatkaa työskentelyä hoidon aikana niin halutessaan. Muussa tapauksessa heidän on voitava jatkaa uraansa niiden jälkeen. Tämän asian pitäisi kuulua vuonna 2000 syrjinnän torjunnasta työpaikalla annetun työelämädirektiivin soveltamisalaan – Yhdistyneessä kuningaskunnassa näin on tehty. Monissa jäsenvaltioissa rintasyöpää ei kuitenkaan luokitella työkyvyttömyydeksi, ja siksi tarvitaan työkyvyttömyyden määritelmä. Asia on korjattava rintasyövän yleisyyden takia.
Lisäksi on vaihdettava parhaita käytäntöjä, etenkin siksi, että jäsenvaltioiden välillä on yli 50 prosentin eroja kuolleisuudessa. Yhteinen tehtävämme on pitää rintasyöpä poliittisen asialistan kärjessä."@fi7
|
| lpv:translated text |
"Κυρία Πρόεδρε, θα ήθελα να ευχαριστήσω και εγώ με τη σειρά μου την κ. Jöns για αυτήν την έξοχη πρωτοβουλία και για τις τρομερές προσπάθειες που έχει καταβάλει.
Ο διά βίου κίνδυνος εμφάνισης καρκίνου του μαστού αφορά, όπως ακούσαμε, μία στις δέκα ευρωπαίες γυναίκες και αποτελεί τη μεγαλύτερη αιτία θανάτου των γυναικών ηλικίας μεταξύ 35 και 59 ετών και τη δεύτερη μεγαλύτερη αιτία θανάτου των γυναικών γενικότερα. Ο κ. Bowis είχε απόλυτο δίκιο: δεν πρέπει να λησμονούμε ότι, παρότι αφορά κυρίως τις γυναίκες, χίλιοι άνδρες πεθαίνουν από καρκίνο του μαστού κάθε χρόνο.
Ωστόσο, τα κράτη μέλη εξακολουθούν να μην κάνουν αρκετά. Με προηγμένες τεχνικές ανίχνευσης, είναι δυνατός ο εντοπισμός του καρκίνου του μαστού σε αρχικό στάδιο. Η Ευρωπαϊκή Επιτροπή εξέδωσε τον Απρίλιο μια νέα δέσμη κατευθυντηρίων γραμμών σχετικά με την ανίχνευση και τη διάγνωση του καρκίνου του μαστού. Υπολόγισαν ότι 32 000 θάνατοι από καρκίνο του μαστού σε ολόκληρη την Ευρώπη θα μπορούσαν να έχουν αποφευχθεί. Εντούτοις, πολλά κράτη μέλη δεν διαθέτουν τεχνικές εγκαταστάσεις ανίχνευσης ή καταρτισμένους νοσηλευτές. Προτρέπω κάθε κράτος μέλος να προσυπογράψει τις ευρωπαϊκές κατευθυντήριες γραμμές αλλά, κυρίως, να τις εφαρμόσει.
Πρέπει να κάνουμε περισσότερα από την άποψη της εκπαίδευσης. Ο τρόπος ζωής, καθώς και η γενετική, μπορούν προφανώς να επηρεάσουν την πιθανότητα εμφάνισης καρκίνου του μαστού. Πρέπει επίσης να διασφαλίσουμε ότι οι ασθενείς στους οποίους γίνεται διάγνωση καρκίνου του μαστού δεν υπόκεινται σε διακρίσεις στον χώρο εργασίας τους, όπως ήδη αναφέρθηκε. Θα πρέπει να τους επιτρέπεται να συνεχίσουν να εργάζονται καθ’ όλη τη διάρκεια της θεραπείας τους, εφόσον το επιθυμούν· εάν πάλι δεν το επιθυμούν, θα πρέπει να είναι σε θέση να επιστρέψουν στην εργασία τους μετά την ολοκλήρωσή της. Αυτό θα πρέπει να καλύπτεται από την οδηγία για την απασχόληση του 2000 σχετικά με την καταπολέμηση των διακρίσεων στον χώρο εργασίας – στο Ηνωμένο Βασίλειο έχει ήδη γίνει. Ωστόσο, πολλά κράτη μέλη δεν χαρακτηρίζουν τον καρκίνο του μαστού ως αναπηρία, και για τον λόγο αυτόν χρειαζόμαστε έναν ορισμό της αναπηρίας. Με τόσο μεγάλο αριθμό ατόμων που εμφανίζουν καρκίνο του μαστού, πρέπει να καθορίσουμε έναν σωστό ορισμό.
Θα πρέπει επίσης να προβούμε σε ανταλλαγή βέλτιστων πρακτικών, ειδικότερα εφόσον οι δείκτες θνησιμότητας ποικίλλουν κατά 50% μεταξύ των κρατών μελών. Εναπόκειται σε εμάς να διατηρήσουμε το εν λόγω ζήτημα σε υψηλή θέση στην πολιτική ημερήσια διάταξη."@el10
|
| lpv:translated text |
".
Mevrouw de Voorzitter, ik wil graag mevrouw Jöns bedanken voor dit prijzenswaardige initiatief. Ze heeft er enorm veel tijd aan besteed.
Europese vrouwen hebben, zoals we hebben gehoord, een kans van een op tien in hun leven dat ze borstkanker ontwikkelen. Borstkanker is de belangrijkste doodsoorzaak van vrouwen tussen de 35 en de 59 jaar en de tweede doodsoorzaak in het algemeen. De heer Bowis had volkomen gelijk: we mogen niet vergeten dat het weliswaar vooral vrouwen zijn die door deze ziekte worden getroffen, maar dat er elk jaar ook duizend mannen aan borstkanker overlijden.
Toch wordt er nog niet genoeg door de lidstaten gedaan. Met geavanceerde screeningstechnieken kan borstkanker in een vroeg stadium worden opgespoord. De Europese Commissie heeft in april nieuwe richtsnoeren uitgegeven met betrekking tot de screening en diagnosticering van borstkanker. Het aantal sterfgevallen in Europa ten gevolge van borstkanker zou hierdoor naar schatting met 32 000 kunnen worden verlaagd. Veel lidstaten beschikken echter niet over de benodigde technische voorzieningen of gespecialiseerde verpleegkundigen. Ik spoor alle lidstaten aan om deze Europese richtsnoeren te onderschrijven, maar vooral om ze uit te voeren.
We moeten meer aan voorlichting doen. Iemands levenswijze en genetische aanleg kunnen kennelijk invloed hebben op het ontstaan van borstkanker. Wat ook al is gezegd, is dat we er tevens voor moeten zorgen dat borstkankerpatiënten niet worden gediscrimineerd in hun werkomgeving. Ze moeten kunnen blijven doorwerken tijdens de behandeling als ze dat willen, en als dat niet gaat, moeten ze naderhand weer hun oude werk kunnen hervatten. Dat valt in principe onder de richtlijn uit 2000 voor gelijke behandeling in arbeid en beroep, zoals bij ons in het Verenigd Koninkrijk ook het geval is. In veel lidstaten wordt borstkanker echter niet als reden voor arbeidsongeschiktheid gezien en daarom moeten we arbeidsongeschiktheid definiëren. Er zijn zoveel mensen die borstkanker krijgen dat we dat goed geregeld moeten hebben.
Er moet ook een uitwisseling van beste praktijken plaatsvinden, vooral omdat er wel 50 procent verschil zit tussen de sterftecijfers in de lidstaten. We moeten er allemaal voor zorgen dat dit onderwerp hoog op de politieke agenda blijft staan."@nl3
|
| lpv:translated text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@lv13
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:spoken text |
"Madam President, I should like to add my thanks to Mrs Jöns for this splendid initiative. She has done a tremendous amount of work on it.
The lifetime risk of developing breast cancer in European women, as we have heard, is one in ten, and it is the biggest killer of women between the ages of 35 to 59, and the second biggest overall. Mr Bowis was absolutely right: we must not forget that although it mainly affects women, one thousand men die of breast cancer each year.
Still not enough is being done by Member States. With advanced screening techniques, it is possible for breast cancer to be identified at an early stage. The European Commission published a new set of guidelines on breast cancer screening and diagnosis in April. They estimated that 32 000 breast cancer deaths across Europe could be prevented. But many Member States do not have technical screening facilities or trained nurses in place. I urge every Member State to sign up to the European guidelines but, more importantly, to implement those guidelines.
We need to do even more in terms of education. Lifestyle, as well as genetics, can apparently affect the likelihood of getting breast cancer. We also need to make sure that those diagnosed with breast cancer are not discriminated against in the workplace, as we have already heard. They should be allowed to continue to work during treatment, if that is what they wish to do; but, if not, to be able to resume their careers afterwards. That should be covered by the 2000 Employment Directive on anti-discrimination in the workplace – we have done that in the United Kingdom. But many Member States do not class breast cancer as a disability, which is why we need a definition of disability. With so many people developing breast cancer, we must get that right.
We must also have an exchange of best practice, particularly as mortality rates vary by 50% between Member States. It is up to us all to keep this high on the political agenda."@en4
|
| lpv:unclassifiedMetadata |
"Elizabeth Lynne,"5,19,15,1,18,14,16,11,13,4
|
| lpv:unclassifiedMetadata |
"on behalf of the ALDE Group"5,19,15,1,18,14,16,11,13,4
|
| lpv:translated text |
"Senhora Presidente, gostaria de me juntar aos agradecimentos à senhora deputada Jöns por esta magnífica iniciativa, nela tendo tido um enorme investimento em termos de trabalho.
O risco de contrair cancro da mama para as mulheres europeias, tal como nos foi dito, é de um para dez, sendo este o maior assassino de mulheres entre os 35 e os 59, e o segundo maior em termos gerais. O senhor deputado Bowis tem toda a razão no que disse: não podemos esquecer que, embora se trate de uma doença que afecta sobretudo as mulheres, um milhar de homens morre de cancro da mama todos os anos.
No entanto, não está a ser feito o suficiente pelos Estados-Membros. Por meio de técnicas de rastreio avançadas, é possível identificar o cancro da mama numa fase precoce. A Comissão Europeia publicou, em Abril, uma nova edição das directrizes sobre exames de rastreio e diagnóstico do cancro da mama. Nestas é estimado que 32 000 mortes por cancro da mama podiam ser evitadas em toda a Europa, mas muitos Estados-Membros não possuem equipamentos técnicos para exames de rastreio, nem dispõem de pessoal de enfermagem formado. Exorto todos os Estados-Membros a adoptarem estas directrizes comunitárias, sendo, contudo, o mais importante a sua aplicação.
Temos de fazer ainda mais em termos de educação. O estilo de vida, assim como a genética, podem aparentemente afectar a probabilidade de contrair cancro da mama. Também precisamos de nos certificar de que um diagnóstico de cancro da mama não tem como consequência a discriminação no local de trabalho, tal como já ouvimos. Nestes casos, deve-se permitir que, as pessoas continuem a trabalhar durante o tratamento, se for essa a sua vontade; mas, se assim não for, que possam retomar as suas carreiras profissionais posteriormente. Este aspecto deveria ser contemplado na Directiva de 2000, sobre o Emprego, relativamente à não discriminação no local de trabalho – fizemos isso no Reino Unido. Mas muitos Estados-Membros não classificam o cancro da mama como doença incapacitante, razão pela qual precisamos de uma definição de incapacidade. Com tanta gente a contrair cancro da mama, vamos ter de cuidar bem deste aspecto.
Temos igualmente de adoptar um intercâmbio de boas práticas, particularmente dado que as taxas de mortalidade apresentam uma variação de 50% entre Estados-Membros. Compete a todos nós manter este ponto em destaque na agenda política."@pt17
|
| lpv:translated text |
".
Señora Presidenta, quiero sumarme al agradecimiento a la señora Jöns por esta espléndida iniciativa. Le ha dedicado mucho trabajado.
El riesgo que padecen las mujeres europeas de desarrollar cáncer de mama en algún momento de su vida, como hemos oído, es de una probabilidad entre diez. Este cáncer es la principal causa de mortalidad entre las mujeres de edades comprendidas entre 35 y 59 años, y la segunda más importante en general. El señor Bowis tiene toda la razón: no debemos olvidar que, aunque afecta principalmente a las mujeres, mil hombres mueren de cáncer de mama cada año.
Los Estados miembros todavía no están haciendo lo suficiente. Con las modernas técnicas de cribado que existen es posible detectar el cáncer de mama en una fase temprana. La Comisión Europea publicó en abril una nueva serie de directrices sobre el cribado y diagnóstico de cáncer de mama. Se calcula que en toda Europa podrían evitarse 32 000 muertes por cáncer de mama. Sin embargo, muchos Estados miembros no cuentan con las instalaciones técnicas necesarias para la mamografía ni con personal de enfermería especializado. Insto a los Estados miembros a que se ajusten a las directrices europeas, pero sobre todo a que las apliquen.
Tenemos que hacer más en el aspecto educativo. El estilo de vida, al igual que la genética, puede influir por lo visto en la probabilidad de contraer cáncer de mama. También tenemos que asegurarnos de que las pacientes a las que se ha diagnosticado la enfermedad no sean discriminadas en el lugar de trabajo, como ya hemos oído. Deberían poder continuar con su trabajo durante el tratamiento, si lo desean; si no, deberían poder reanudar su carrera una vez finalizado. Esto debería estipularse en la Directiva sobre el empleo del año 2000 en materia de no discriminación en el lugar de trabajo. En el Reino Unido lo hemos hecho. Sin embargo, muchos Estados miembros no consideran el cáncer de mama una discapacidad, y por eso necesitamos una definición de la discapacidad. Con tantas personas enfermas de cáncer de mama, hace falta cubrir esta carencia.
También tiene que haber un intercambio de mejores prácticas, en particular porque las tasas de mortalidad varían en un 50 % entre Estados miembros. Todos debemos procurar que este asunto se mantenga entre las máximas prioridades políticas."@es20
|
| lpv:translated text |
".
Frau Präsidentin! Ich möchte mich den Dankesworten an Frau Jöns für diese ausgezeichnete Initiative anschließen. Sie hat eine gewaltige Arbeit dazu geleistet.
Das lebenslange Risiko europäischer Frauen, an Brustkrebs zu erkranken, liegt, wie wir gehört haben, bei eins zu zehn, und es ist die Haupttodesursache bei Frauen im Alter von 35 bis 59 Jahren und steht insgesamt an zweiter Stelle. Herr Bowis hat vollkommen Recht: Wir dürfen nicht vergessen, dass zwar vor allem Frauen davon betroffen sind, aber auch jedes Jahr eintausend Männer an Brustkrebs sterben.
Von den Mitgliedstaaten wird nach wie vor nicht genug getan. Mit moderneren Screening-Verfahren kann Brustkrebs in einem frühen Stadium entdeckt werden. Die Europäische Kommission hat im April neue Leitlinien zum Brustkrebs-Screening und zur Brustkrebsdiagnose veröffentlicht. Sie schätzt, dass europaweit 32 000 Todesfälle infolge von Brustkrebs verhindert werden könnten. Doch viele Mitgliedstaaten verfügen nicht über die technischen Screening-Einrichtungen oder geschulte Krankenschwestern. Ich fordere alle Mitgliedstaaten dringend auf, sich diesen europäischen Leitlinien anzuschließen, vor allem aber, diese Leitlinien auch umzusetzen.
Wir müssen sogar noch mehr im Bereich der Bildung tun. Offenbar können der Lebensstil ebenso wie die genetischen Faktoren die Wahrscheinlichkeit einer Brustkrebserkrankung beeinflussen. Außerdem müssen wir dafür sorgen, dass diejenigen, bei denen Brustkrebs diagnostiziert wird, nicht am Arbeitsplatz diskriminiert werden, wie wir ja bereits gehört haben. Es sollte ihnen möglich sein, während der Behandlung weiterzuarbeiten, wenn sie möchten, und falls nicht, hinterher wieder ins Berufsleben zurückzukehren. Dies könnte in der Richtlinie zur Gleichbehandlung im Bereich der Beschäftigung 2000 geregelt werden, wir haben das im Vereinigten Königreich getan. Aber viele Mitgliedstaaten führen Brustkrebs nicht als Behinderung, weshalb wir eine Definition von Behinderung brauchen. Wenn so viele Menschen an Brustkrebs erkranken, müssen wir das richtig regeln.
Wir brauchen auch einen Austausch zu bewährten Praktiken, insbesondere von Schwankungen bei den Mortalitätsraten zwischen den Mitgliedstaaten um 50 %. Es liegt an uns allen, dass dieses Thema weiter ganz oben auf der politischen Tagesordnung steht."@de9
|
| lpv:translated text |
".
Signora Presidente, desidero aggiungere i miei ringraziamenti all’onorevole Jöns per la sua splendida iniziativa. La collega ha affrontato con grande impegno questo problema.
Le donne europee, come abbiamo sentito, durante la propria vita, hanno una probabilità su dieci di essere colpite da un tumore al seno. Il cancro al seno è inoltre la principale causa di morte per le donne di età compresa tra 35 e 59 anni, e la seconda causa di morte in assoluto. L’onorevole Bowis ha assolutamente ragione: non dobbiamo dimenticare che, sebbene questa patologia colpisca prevalentemente le donne, ogni anno muoiono di carcinoma mammario mille uomini.
Ma gli Stati membri non fanno ancora abbastanza. Grazie a sofisticate tecniche di
è ora possibile individuare il tumore della mammella in una fase precoce. Ad aprile la Commissione europea ha pubblicato una nuova serie di linee guida per lo
e la diagnosi del tumore al seno. Secondo le stime in esse contenute, in Europa 32 000 decessi per cancro al seno potrebbero essere evitati. Tuttavia molti Stati membri non dispongono di apparecchiature tecniche per lo
né di personale infermieristico adeguatamente formato. Invito tutti gli Stati membri a sottoscrivere le linee guida europee ma, soprattutto, a dare loro esecuzione.
Dobbiamo fare ancora di più in termini di informazione. Lo stile di vita e i fattori genetici possono apparentemente incidere sulla probabilità di ammalarsi di cancro al seno. Dobbiamo anche fare in modo che le persone cui viene diagnosticato un carcinoma mammario non siano discriminate sul luogo di lavoro, come abbiamo già sentito. Dovrebbero avere la possibilità di continuare a lavorare durante il trattamento, se è quello che desiderano fare. Se invece preferiscono non lavorare, dovrebbero avere la possibilità di riprendere successivamente il loro percorso professionale. Tali misure dovrebbero rientrare nel campo di applicazione della direttiva sull’occupazione del 2000 concernente le norme antidiscriminatorie sul posto di lavoro; nel Regno Unito abbiamo provveduto in tal senso. Molti Stati membri, però, non classificano il tumore della mammella tra le invalidità, per questo abbiamo bisogno di una definizione dell’invalidità. Visto l’elevato numero di persone colpite dal tumore della mammella, dobbiamo colmare questa lacuna.
Dobbiamo anche garantire lo scambio di migliori pratiche, soprattutto se si considera che i tassi di mortalità variano del 50 per cento da uno Stato membro all’altro. Spetta a tutti noi continuare a fare sì che questo tema figuri al vertice della nostra agenda politica."@it12
|
| lpv:unclassifiedMetadata | |
| lpv:translated text |
"Madame la Présidente, je voudrais moi aussi remercier Mme Jöns pour sa merveilleuse initiative. Elle a fait un travail extraordinaire sur ce sujet.
Comme nous l’avons entendu, les femmes européennes ont une chance sur dix de développer un cancer du sein au cours de leur vie, et il s’agit de la première cause de décès chez les femmes de 35 à 59 ans, et de la deuxième en général. M. Bowis a absolument raison: nous ne devons pas oublier que s’il frappe surtout les femmes, le cancer du sein tue mille hommes chaque année.
Les États membres n’en font pas encore assez. Avec les techniques avancées de dépistage, la détection précoce du cancer du sein est possible. La Commission européenne a publié en avril une nouvelle série de lignes directrices sur le dépistage et le diagnostic du cancer du sein. Selon ses estimations, 32 000 décès liés au cancer du sein pourraient être évités en Europe. De nombreux États membres ne disposent toutefois pas d’infrastructures techniques de dépistage ni d’infirmières formées. Je demande instamment à tous les États membres d’adhérer aux lignes directrices européennes, mais surtout, de les appliquer.
Nous devons faire bien davantage en matière d’éducation. Le style de vie et les facteurs génétiques peuvent apparemment influer sur la probabilité de développer un cancer du sein. Nous devons également veiller à ce que les personnes souffrant d’un cancer du sein ne fassent pas l’objet d’une discrimination sur leur lieu de travail, comme nous l’avons déjà entendu. Elles devraient pouvoir continuer à travailler pendant leur traitement, si tel est leur souhait; dans le cas contraire, elles doivent pouvoir reprendre leur travail par la suite. Cela devrait être couvert par la directive adoptée en 2000 en matière d’emploi concernant la lutte contre la discrimination sur le lieu de travail - nous l’avons fait au Royaume-Uni. Bon nombre d’États membres ne considèrent toutefois pas le cancer du sein comme un handicap, raison pour laquelle nous avons besoin d’une définition du terme «handicap». Vu le grand nombre de personnes développant un cancer du sein, il s’agit de ne pas nous tromper.
Nous devons également échanger les meilleures pratiques, en particulier vu que le taux de mortalité varie de 50 % d’un État membre à l’autre. Il nous incombe à tous de maintenir ce point en haut de l’agenda politique."@fr8
|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20061024.5.2-036"6
|
| lpv:hasSubsequent | |
| lpv:speaker |
Named graphs describing this resource:
The resource appears as object in 2 triples